|
Novel treatment for pseudomyxoma peritonei
Reference #: 1692
The University of South Carolina is offering licensing opportunities for Novel treatment for pseudomyxoma peritonei.
Background:
Pseudomyxoma peritonei (PMP) is a rare cancer, which originates as an appendiceal neoplasm. Due to its usually poor vascularization and floating as nodules, PMP spreads easily to the peritoneal cavity,...
Published: 7/10/2026
|
Updated: 6/11/2024
|
Inventor(s): Jie Li, Daping Fan, Hexin Chen, Traci Testerman
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Immunomodulating Activities of Alistipes and Its Metabolites: Mechanism and Application
Reference #: 1678
The University of South Carolina is offering licensing opportunities for Immunomodulating Activities of Alistipes and Its Metabolites: Mechanism and Application.
Background:
The gut microbiota plays a key role in health and disease. The balance between beneficial genera (such as Alistipes and Odoribacter) and harmful species (such...
Published: 2/9/2026
|
Updated: 6/11/2024
|
Inventor(s): Jie Li, Hexin Chen, Daping Fan
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
A novel formulation of nutraceutical compounds--PHMHP
Reference #: 1665
The University of South Carolina is offering licensing opportunities for A novel formulation of nutraceutical compounds--PHMHP.
Background:
Natural compounds such as quercetin and emodin hold a great promise to be developed as therapeutic agents for various diseases such as cancer, cardiovascular disease, Alzheimer’s disease,...
Published: 5/16/2025
|
Updated: 4/26/2024
|
Inventor(s): Daping Fan
Keywords(s):
Category(s): Biomedical and Life Sciences
|
|
Cannabis Plant Material as an Agent for Mitigating Metabolic Syndrome
Reference #: 01640
The University of South Carolina is offering licensing opportunities for Cannabis Plant Material as an Agent for Mitigating Metabolic Syndrome.
Background:
A symptom of metabolic syndrome is insulin resistance, defined as the inability of insulin to optimally stimulate the transport of glucose into the body’s cell (hyperinsulinemia...
Published: 3/25/2025
|
Updated: 4/24/2024
|
Inventor(s): Angela Murphy, Daping Fan, Kandy Velazquez, Reilly Enos, Brandon VanderVeen
Keywords(s):
Category(s): Biomedical and Life Sciences, Chemistry and Biochemistry
|
|
The value of microRNA-155 in breast cancer prognosis and treatment
Reference #: 01608
The University of South Carolina is offering licensing opportunities for The value of microRNA-155 in breast cancer prognosis and treatment
Background:
In the US in 2021, there were an estimated 281,550 new cases of invasive breast cancer diagnosed in women; 2,650 cases diagnosed in men. An estimated 44,130 breast cancer deaths...
Published: 7/10/2026
|
Updated: 10/26/2022
|
Inventor(s): Daping Fan, Junfeng Wang,
Keywords(s): breast cancer, immune therapy, microRNA, microRNA-155, predictive biomarker, prognosis
Category(s): Health Sciences, Biomedical and Life Sciences
|
|
Emodin Inhibits Colorectal Tumorigenesis and Ameliorates Toxicity Associated With Chemotherapy
Reference #: 01294
The University of South Carolina is offering licensing opportunities for Emodin Inhibits Colorectal Tumorigenesis and Ameliorates Toxicity Associated with Chemotherapy
Background:
Colorectal cancer is one of the most common malignancies, accounting for approximately 1.36 million new cases worldwide annually. It is the third most...
Published: 9/4/2022
|
Updated: 6/18/2021
|
Inventor(s): Daping Fan, Angela Murphy
Keywords(s):
Category(s): Health Sciences, Chemistry and Biochemistry, Biomedical and Life Sciences
|
|
MicroRNA-155 Enhances the Efficacy of Dendritic Cell Vaccine for Cancer
Reference #: 01197The University of South Carolina is offering licensing opportunities for nanoparticle delivery tools (microRNA transfection) that enhance the efficacy of dendritic cell vaccines for cancer.Background:In anti-tumor immunity, dendritic cells (DCs) capture, process, and present tumor antigens to T cells, initiating a tumoricidal response....
Published: 7/2/2026
|
Updated: 6/26/2016
|
Inventor(s): Daping Fan
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Sparstolonin B in Neuroblastoma Treatment
Reference #: 01056The University of South Carolina is offering licensing opportunities for this novel treatment of neuroblastoma.Invention Description:This invention is derived from a novel, naturally occurring compound, Sparstolonin B (SsnB), which is isolated from the tubers of an aquatic Chinese herb, Sparganium stoloniferum. The crude extract prepared...
Published: 5/27/2021
|
Updated: 11/1/2013
|
Inventor(s): Ambrish Kumar, Ugra Singh, Daping Fan, Donald Dipette
Keywords(s):
Category(s): Biomedical and Life Sciences, Health Sciences
|
|
Novel Peptide Derived from Human Apolipoprotein E Inhibits Hepatitis C Virus Entry
Reference #: 00885
The University of South Carolina is offering licensing opportunities for this novel method of blocking and/or treating Hepatitis C Virus.
Invention Description:
This invention is a human apolipoprotein E (apoE) peptide, designated hEP. hEP blocks Hepatitis C Virus (HCV) entry into hepatocytes. This peptide specifically blocks...
Published: 3/1/2018
|
Updated: 7/5/2012
|
Inventor(s): Daping Fan, Tianyi Wang, Shufeng Liu
Keywords(s):
Category(s): Biomedical and Life Sciences
|